Abstract
Acinetobacter species are becoming a major cause of nosocomial infections, including hospital-acquired and ventilator-associated pneumonia. Acinetobacter species have become increasingly resistant to antibiotics over the past several years and currently present a significant challenge in treating these infections. Physicians now rely on older agents, such as polymyxins (colistin), for treatment. This paper reviews the epidemiology, treatment, and prevention of this emerging pathogen.
| Original language | English |
|---|---|
| Article number | 4 |
| Journal | MedGenMed Medscape General Medicine |
| Volume | 9 |
| Issue number | 3 |
| State | Published - 2007 |